COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
09/07/2024
SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued [...]
Aviv Clinics Spotlights New Study Sharing Further Evidence That Specific Hyperbaric Oxygen Therapy is Effective in Fighting Aging
09/07/2024
This new study focused on physical enhancement in aging adults follows two studies related to cognitive decline and biological aging, showing the potential dedicated protocol of hyperbaric oxygen therapy has to change [...]
Zevra Announces FDA Advisory Committee Meeting to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C
09/07/2024
Meeting with the recently formed GeMDAC set for August 2, 2024 CELEBRATION, Fla., July 09, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company [...]
Aeroflow Health Announces its Family Forward NC Certification
09/07/2024
As a Family Forward NC certified employer, Aeroflow Health is recognized as a business with established policies and practices to support its working parents and their children ASHEVILLE, N.C., July 09, 2024 (GLOBE [...]
Raphael Pharmaceutical Issues Letter to Shareholders
09/07/2024
Highlights Company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical [...]
CytoDyn Announces Settlement with Amarex Clinical Research LLC
09/07/2024
Terms of the settlement include $12,000,000 cash payment to CytoDyn and elimination of $14,000,000 accounts payable liability from the Company’s balance sheet VANCOUVER, Washington, July 09, 2024 (GLOBE NEWSWIRE) -- [...]
Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
09/07/2024
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the [...]
Smart for Life Announces Appointment of Jessica Walters as Chief Marketing Officer
09/07/2024
CMO Expected to Position Smart for Life for Long Term Growth and Utilize IP from Acquisitions to Increase Sales Opportunities MIAMI, July 09, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life [...]
Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline
09/07/2024
Robert Hayes issues a letter to shareholders asking their voting approval on three proposals vital to the Company’s continued growth. Voting deadline is Friday, July 12, at 11:59 p.m. Eastern Time. NEW YORK, July 09, [...]
Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
09/07/2024
NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Business Combination to August 3, 2024
08/07/2024
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “ Company ”) a special purpose acquisition company, announced today that on July 2, 2024, its sponsor, [...]
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
08/07/2024
AMF Regulated Information Montrouge, France, July 8, 2024 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a [...]
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
08/07/2024
Informations Réglementées Montrouge, France, le 8 juillet 2024 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire [...]
Travere Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
08/07/2024
SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference on Monday, July 15 [...]
Ryan Saadi Congratulates Marc Benioff on Receiving the Yale Legend in Leadership Award and Commends Yale School of Management for Recognizing the Importance of Integrating Corporate Success with Social Responsibility
08/07/2024
WARREN, N.J., July 08, 2024 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, founding CEO of Tevogen Bio (“Tevogen”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, [...]
QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
08/07/2024
Partnership with University of Montana drives the implementation of next-generation sequencing and forensic investigative genetic genealogy in identifying human remains // QIAGEN provides instruments, kits and training [...]
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
08/07/2024
PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees. Effective July 1, [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
08/07/2024
GAITHERSBURG, Md., July 08, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune [...]
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call
08/07/2024
BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]

Pages